1. 239. Technical feasibility and validity of sentinel lymph node biopsy after ipsilateral breast tumor recurrence. Issue 9 (September 2016) Authors: Matsumoto, A.; Jinno, H.; Takahashi, M.; Hayashida, T.; Kitagawa, Y. Journal: European journal of surgical oncology Issue: Volume 42:Issue 9(2016:Sep.) Page Start: S132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 89. The non-invasive treatment for sentinel lymph node metastasis by photodynamic therapy using verteporfin nanoparticles. Issue 9 (September 2016) Authors: Jinno, H.; Matsuda, S.; Shimada, K.; Konno, T.; Ishihara, K.; Kitagawa, Y. Journal: European journal of surgical oncology Issue: Volume 42:Issue 9(2016:Sep.) Page Start: S103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase II trial of the combination of S-1 and paclitaxel followed by 5-FU/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with HER2-negative, stage II/III breast cancer. (March 2017) Authors: Takahashi, Y.; Jinno, H.; Yoshikawa, M.; Matsumoto, A.; Ikeda, T. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparative analysis of respiratory and skin sensitization potential of chemicals using Japanese GHS classification. (16th September 2016) Authors: Ono, A.; Jinno, H.; Hirose, A. Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evaluation of the OECD QSAR toolbox in the screening of chemical sensitizer. (10th October 2016) Authors: Ono, A.; Jinno, H.; Hirose, A. Journal: Toxicology letters Issue: Volume 259(2016)Supplement Page Start: S228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Omission of axillary dissection after neoadjuvant chemotherapy for node-positive primary breast cancer. (October 2020) Authors: Matsumoto, A.; Yasuko, U.; Tsukahara, D.; Jinno, H. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P057 Breast cancer-specific signatures in saliva metabolites for early diagnosis. (March 2015) Authors: Jinno, H.; Murata, T.; Sunamura, M.; Sugimoto, M.; Kitagawa, Y. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P166 Thymidylate synthase is a significant predictive factor of S-1 in metastatic breast cancer patients. (March 2015) Authors: Seki, H.; Jinno, H.; Hayashida, T.; Takahashi, M.; Asanuma, F.; Osaku, M.; Kitagawa, Y. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P207 Prognostic significance of biomarker discordance after neoadjuvant chemotherapy in breast cancer. (March 2015) Authors: Matsumoto, A.; Jinno, H.; Ando, T.; Fujii, T.; Nakamura, T.; Saito, J.; Takahashi, M.; Hayashida, T.; Kitagawa, Y. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Salivary metabolomics with artificial intelligence-based methods for breast cancer detection and subtype prediction. (October 2020) Authors: Murata, T.; Yanagisawa, T.; Kurihara, T.; Kaneko, M.; Ota, S.; Enomoto, A.; Tomita, M.; Sugimoto, M.; Sunamura, M.; Hayashida, T.; Jinno, H.; Kitagawa, Y. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗